FDNA is a digital health company specializing in the use of artificial intelligence and deep learning to advance precision medicine, particularly in the field of rare genetic disorders. By developing innovative facial recognition and analysis technology, FDNA's platform can assess phenotypic information to support the identification and diagnosis of various genetic conditions. The company's tools are designed for use by healthcare professionals and researchers to enhance diagnostic accuracy and facilitate personalized treatment strategies.